Articles

Routine clinical parameters and laboratory testing predict therapy related myeloid neoplasms after treatment for breast cancer

Department of Medicine, Mount Sinai Morningside and Mount Sinai West, New York, NY
Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix
Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY
Division of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Haematologica Early view Jun 30, 2022 https://doi.org/10.3324/haematol.2021.280437